Table of Contents Table of Contents
Previous Page  42 / 49 Next Page
Information
Show Menu
Previous Page 42 / 49 Next Page
Page Background

RELAY: phase 1b/III study of erlotinib + ramucirumab in

EGFR

Mut+ patients

1 … 37 38 39 40 41 42 43 44 45 46 47 48 49  FlippingBook